234 related articles for article (PubMed ID: 29578940)
1. RELATIONSHIP OF CLINICAL FEATURES AND BASELINE TUMOR SIZE WITH GENE EXPRESSION PROFILE STATUS IN UVEAL MELANOMA: A Multi-institutional Study.
Berry D; Seider M; Stinnett S; Mruthyunjaya P; Schefler AC;
Retina; 2019 Jun; 39(6):1154-1164. PubMed ID: 29578940
[TBL] [Abstract][Full Text] [Related]
2. CORRELATION OF GENE EXPRESSION PROFILE STATUS AND AMERICAN JOINT COMMISSION ON CANCER STAGE IN UVEAL MELANOMA.
Berry DE; Schefler AC; Seider MI; Materin M; Stinnett S; Mruthyunjaya P;
Retina; 2020 Feb; 40(2):214-224. PubMed ID: 31972790
[TBL] [Abstract][Full Text] [Related]
3. Relationship between clinical features, GEP class, and PRAME expression in uveal melanoma.
Schefler AC; Koca E; Bernicker EH; Correa ZM
Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1541-1545. PubMed ID: 31065847
[TBL] [Abstract][Full Text] [Related]
4. Gene Expression Profiling Prognostication of Posterior Uveal Melanoma: Does Size Matter?
Binkley EM; Bena JF; Davanzo JM; Hinz C; Boldt HC; Singh AD
Ophthalmol Retina; 2020 Jun; 4(6):620-629. PubMed ID: 32081600
[TBL] [Abstract][Full Text] [Related]
5. Association between traditional clinical high-risk features and gene expression profile classification in uveal melanoma.
Nguyen BT; Kim RS; Bretana ME; Kegley E; Schefler AC
Graefes Arch Clin Exp Ophthalmol; 2018 Feb; 256(2):421-427. PubMed ID: 29185101
[TBL] [Abstract][Full Text] [Related]
6. Association between Tumor Regression Rate and Gene Expression Profile after Iodine 125 Plaque Radiotherapy for Uveal Melanoma.
Mruthyunjaya P; Seider MI; Stinnett S; Schefler A;
Ophthalmology; 2017 Oct; 124(10):1532-1539. PubMed ID: 28549517
[TBL] [Abstract][Full Text] [Related]
7. Validation of the Prognostic Usefulness of the Gene Expression Profiling Test in Patients with Uveal Melanoma.
Miguez S; Lee RY; Chan AX; Demkowicz PC; Jones BSCL; Long CP; Abramson DH; Bosenberg M; Sznol M; Kluger H; Goldbaum MH; Francis JH; Pointdujour-Lim R; Bakhoum MF
Ophthalmology; 2023 Jun; 130(6):598-607. PubMed ID: 36739981
[TBL] [Abstract][Full Text] [Related]
8. Multi-center analysis of intraocular biopsy technique and outcomes for uveal melanoma: Ocular Oncology Study Consortium report 4.
Seider MI; Berry DE; Schefler AC; Materin M; Stinnett S; Mruthyunjaya P;
Graefes Arch Clin Exp Ophthalmol; 2020 Feb; 258(2):427-435. PubMed ID: 31807898
[TBL] [Abstract][Full Text] [Related]
9. Gene Expression Profiling and PRAME Status Versus Tumor-Node-Metastasis Staging for Prognostication in Uveal Melanoma.
Cai L; Paez-Escamilla M; Walter SD; Tarlan B; Decatur CL; Perez BM; Harbour JW
Am J Ophthalmol; 2018 Nov; 195():154-160. PubMed ID: 30092184
[TBL] [Abstract][Full Text] [Related]
10. Relationship between rate of posterior uveal melanoma flattening following plaque radiotherapy and gene expression profile class of tumor cells.
Corrêa ZM; Augsburger JJ
Invest Ophthalmol Vis Sci; 2014 Jan; 55(1):556-9. PubMed ID: 24408979
[TBL] [Abstract][Full Text] [Related]
11. Independent Prognostic Significance of Gene Expression Profile Class and Largest Basal Diameter of Posterior Uveal Melanomas.
Corrêa ZM; Augsburger JJ
Am J Ophthalmol; 2016 Feb; 162():20-27.e1. PubMed ID: 26596399
[TBL] [Abstract][Full Text] [Related]
12. Cytogenetic Abnormalities in Uveal Melanoma Based on Tumor Features and Size in 1059 Patients: The 2016 W. Richard Green Lecture.
Shields CL; Say EAT; Hasanreisoglu M; Saktanasate J; Lawson BM; Landy JE; Badami AU; Sivalingam MD; Mashayekhi A; Shields JA; Ganguly A
Ophthalmology; 2017 May; 124(5):609-618. PubMed ID: 28159380
[TBL] [Abstract][Full Text] [Related]
13. Collaborative Ocular Oncology Group report number 1: prospective validation of a multi-gene prognostic assay in uveal melanoma.
Onken MD; Worley LA; Char DH; Augsburger JJ; Correa ZM; Nudleman E; Aaberg TM; Altaweel MM; Bardenstein DS; Finger PT; Gallie BL; Harocopos GJ; Hovland PG; McGowan HD; Milman T; Mruthyunjaya P; Simpson ER; Smith ME; Wilson DJ; Wirostko WJ; Harbour JW
Ophthalmology; 2012 Aug; 119(8):1596-603. PubMed ID: 22521086
[TBL] [Abstract][Full Text] [Related]
14. Tumor-height regression rate after brachytherapy between choroidal melanoma gene expression profile classes: effect of controlling for tumor height.
Gupta K; McCannel CA; Kamrava M; Lamb J; Almanzor RD; McCannel TA
Graefes Arch Clin Exp Ophthalmol; 2016 Jul; 254(7):1371-8. PubMed ID: 26907932
[TBL] [Abstract][Full Text] [Related]
15. Yield, Techniques, and Complications of Transvitreal and Transscleral Biopsies in Small Uveal Melanoma.
Kim RS; Chevez-Barrios P; Divatia M; Bretana ME; Teh B; Schefler AC
JAMA Ophthalmol; 2018 May; 136(5):482-488. PubMed ID: 29596552
[TBL] [Abstract][Full Text] [Related]
16. MOLECULAR PROGNOSTICS FOR UVEAL MELANOMA.
Seider MI; Mruthyunjaya P
Retina; 2018 Feb; 38(2):211-219. PubMed ID: 28665870
[TBL] [Abstract][Full Text] [Related]
17. Gene expression profiling in uveal melanoma: technical reliability and correlation of molecular class with pathologic characteristics.
Plasseraud KM; Wilkinson JK; Oelschlager KM; Poteet TM; Cook RW; Stone JF; Monzon FA
Diagn Pathol; 2017 Aug; 12(1):59. PubMed ID: 28778171
[TBL] [Abstract][Full Text] [Related]
18. Gene expression profiling and regression rate of irradiated uveal melanomas.
Rao RC; Khan M; Badiyan SN; Harbour JW
Ophthalmic Surg Lasers Imaging Retina; 2015 Mar; 46(3):333-7. PubMed ID: 25856819
[TBL] [Abstract][Full Text] [Related]
19. Prognostic biomarkers in uveal melanoma: evidence for a stem cell-like phenotype associated with metastasis.
Chang SH; Worley LA; Onken MD; Harbour JW
Melanoma Res; 2008 Jun; 18(3):191-200. PubMed ID: 18477893
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneity revealed by integrated genomic analysis uncovers a molecular switch in malignant uveal melanoma.
de Lange MJ; van Pelt SI; Versluis M; Jordanova ES; Kroes WG; Ruivenkamp C; van der Burg SH; Luyten GP; van Hall T; Jager MJ; van der Velden PA
Oncotarget; 2015 Nov; 6(35):37824-35. PubMed ID: 26462151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
